Introduction
============

Since the 1990s, community-acquired methicillin-resistant *Staphylococcus aureus* (CA-MRSA) infections have been increasing worldwide ([@ref-8]; [@ref-18]). CA-MRSA clones are known to be more virulent than hospital-acquired MRSA, with infections linked to significant mortality and morbidity ([@ref-9]; [@ref-12], [@ref-11]; [@ref-25]; [@ref-30]; [@ref-44]). First reported in Australia and the United States, CA-MRSA occurrence has been increasing, with epidemics due to clones such as ST8 USA300 in the United States ([@ref-22]), ST93 and ST1 in Australia ([@ref-15]), ST80 in Europe ([@ref-38]), ST59 in China and Taiwan ([@ref-10]), ST772 in India ([@ref-16]; [@ref-19]; [@ref-35]; [@ref-45]) and ST72 in South Korea ([@ref-29]). Other identified CA-MRSA clones belong to ST30 (South West Pacific clone) ([@ref-48]), ST45 (Berlin clone) ([@ref-49]), ST1 (USA400) ([@ref-19]) and ST78 (Western Australian MRSA-2) ([@ref-48]). In Africa, the distribution of MRSA clones in general is not well understood ([@ref-1]). A recent review on MRSA in Africa with data from 15 of the 54 countries identified community clones of ST8-IV \[2B\] (USA300) and ST88-IV \[2B\] "West Australia MRSA-2 clone" in both community and health care associated infections in seven countries and a "Brazilian/Hungarian clone" ST239-III \[3A\] in hospital acquired infections in nine countries ([@ref-1]). The European ST80-IV \[2B\] clone was limited to Algeria, Egypt and Tunisia while clonal types ST22-IV \[2B\], ST36-II \[2A\] and ST612-IV \[2B\] have only been reported so far in South Africa ([@ref-1]). Among the two CA-MRSA clones, the ST8IV \[2B\] clone is an internationally disseminated clone recognized in every continent except Antarctica ([@ref-17]). The ST88-IV \[2B\] CA-MRSA clone however is predominant in Sub-Saharan Africa (West, Central and East Africa) with reported rates of 24.2--83.3% of all MRSA isolates ([@ref-42]). Studies from Angola ([@ref-14]), Cameroon ([@ref-7]), Gabon ([@ref-36]; [@ref-43]), Ghana ([@ref-3]; [@ref-23], [@ref-24]), Madagascar ([@ref-7]), Niger ([@ref-7]), Nigeria ([@ref-28]; [@ref-41]; [@ref-46]) and Senegal ([@ref-7]) have identified it as a major circulating clone within both hospital and community settings. It was also detected in children from West Africa who underwent surgery in Switzerland but had been hospitalized in their home countries prior to surgical treatment ([@ref-6]). Globally, this clone has been identified in China ([@ref-50]) and Japan ([@ref-33]) in lower proportion (5.3--12.5%) than in Africa and sporadically in Belgium ([@ref-20]), Portugal ([@ref-2]) and Sweden ([@ref-26]).

Control of MRSA infections is assisted by a thorough knowledge of the epidemiology and dissemination of specific clones. To this end, we employed whole genome sequencing and comparative genomics to describe in detail ST88 CA-MRSA isolates in comparison to other MRSA lineages worldwide.

Materials and Methods
=====================

Bacterial isolates and antibiogram analysis
-------------------------------------------

The 17 ST88 *S. aureus* isolates analysed from Ghana are listed in [Table 1](#table-1){ref-type="table"} and comprised five strains isolated in the Akwapim South District (Eastern Region) of Ghana with previously published genome data (GenBank accession numbers: [LFNJ00000000](LFNJ00000000), [LFNI00000000](LFNI00000000), [LFNH00000000](LFNH00000000), [LFMH00000000](LFMH00000000), [LFMG00000000](LFMG00000000)) ([@ref-3]) and 12 isolates recovered from wounds of 11 patients attending Buruli ulcer (BU) treatment centres in the Ga-South and Ga-West municipalities (Greater Accra Region) of Ghana with two isolates from one patient; one a PVL positive isolate and the other PVL negative. Patients were outpatients, nine of whom had laboratory confirmed BU. Initial isolate identification was made using colony and microscopic morphology, catalase and coagulase biochemical reactions and a Staphylase kit BD BBL™ Staphyloslide Latex Test (Becton, Dickinson and Company, NJ, USA) for further confirmation. Antibiograms were determined using the Kirby Bauer disc diffusion method according to CLSI guidelines ([@ref-13]) and PCR targeting the *mecA* gene ([@ref-37]) for identification of MRSA. Ethical clearance was obtained from the institutional review board of the Noguchi Memorial Institute for Medical Research (NMIMR) (Federal-wide Assurance number FWA00001824). All study participants were well informed of the study objectives and written informed consent was obtained either from the patient or from the guardian of the patient.
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###### *S. aureus* ST88 isolates tested in this study.
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  Isolate ID    Origin (Ghana)         Phenotypic resistance                                              Genotype (*spa*, *agr*, PVL)                    Reference
  ------------- ---------------------- ------------------------------------------------------------------ ----------------------------------------------- ------------
  Sa_NOG-W02    Greater Accra Region   cld, tet, amp, ery, fox, ctx, chl, cro                             t939, agr-3, PVL+                               This study
  Sa_NOG-W25    Greater Accra Region   gen, amk, cld, str, amp, tet, sxt, cfx, ctx, chl, cro              t448, agr-3, PVL−                               This study
  Sa_NOG-W11    Greater Accra Region   str, amk, gen, sxt, cfx, cld, fox, ctx, tet, chl, cro, amp, ery    t186, agr-3, PVL+                               This study
  Sa_NOG-W13    Greater Accra Region   gen, str, amk, ctx, tet, chl, cro, sxt, cfx, amp, cld, fox         07-12-12-118-13-13, agr-3, PVL+                 This study
  Sa_NOG-W01    Greater Accra Region   amk, cfx, tet, ctx, chl, cro, fox                                  t186, agr-3, PVL+                               This study
  Sa_NOG-W10    Greater Accra Region   sxt, ery, gen, str, amk, cld, amp, cfx, tet, fox, ctx, chl, cro    t186, agr-3, PVL−                               This study
  Sa_NOG-W07    Greater Accra Region   gen, str, amp, tet, sxt, cfx, chl, cro, ctx, fox, cld, ery,        t448, agr-3, PVL−                               This study
  Sa_NOG-W14    Greater Accra Region   gen, ery, sxt, amk, cld, str, tet, amp, cfx, ctx, chl, cro, fox,   t2649, agr-3, PVL+                              This study
  Sa_NOG-W04    Greater Accra Region   sxt, ery, gen, str, amk, amp, cfx, tet, fox, ctx, chl, cro         07-12-21-17-13-13-34-34-33-34-34, agr-3, PVL−   This study
  Sa_NOG-W06    Greater Accra Region   sxt, gen, amk, cld, amp, tet, cfx, fox, chl, cro                   t786, agr-3, PVL−                               This study
  Sa_NOG-W24    Greater Accra Region   gen, sxt, amk, str, amp, tet, cfx, ctx, chl, cro, fox,             t786, agr-3, PVL+                               This study
  Sa_NOG-W05    Greater Accra Region   ery, amk, str, amp, cfx, tet, sxt, cld,                            t186, agr-3, PVL−                               This study
  BU_G0701_t5   Eastern Region         fox, ben, oxa, tet, chl                                            t786, agr-3, PVL−                               [@ref-3]
  BU_G0201_t8   Eastern Region         fox, ben, oxa, tet, chl                                            t786, agr-3, PVL−                               [@ref-3]
  BU_G0202_t2   Eastern Region         fox, ben, oxa, tet, chl                                            t786, agr-3, PVL−                               [@ref-3]
  BU_G1905_t3   Eastern Region         fox, ben, oxa, tet, chl                                            t786, agr-3, PVL−                               [@ref-3]
  BU_W13_11     Eastern Region         fox, ben, oxa, tet, chl                                            t186, agr-3, PVL−                               [@ref-3]

**Notes:**

oxa, Oxacillin; fox, cefoxitin; tet, tetracycline; chl, chloramphenicol; cfx, cefuroxime; ery, erythromycin; cld, clindamycin; sxt, sulphamethxazole-trimethoprim; amk, amikacin; str, streptomycin; amp, ampicillin; ctx, cefotaxime; cro, ceftriaxone; gen, gentamicin; ben, benzylpenicillin; *spa, Staphylococcus aureus;* Protein A, *agr,* Accesory Gene regulator; PVL, Pantone Valentine Leukocidin toxin.

DNA extraction, whole genome sequencing and analysis
----------------------------------------------------

Genomic DNA was extracted from isolates using the Qiagen DNeasy kit and protocol (Qiagen, Hilden, Germany). DNA libraries were prepared using Nextera XT (Illumina, San Diego, CA, USA) and whole genome sequencing was performed using the Illumina MiSeq with 2 × 300 bp chemistry. Small Molecular Real Time sequencing was performed on the RS-II (Pacific Biosciences, California, United States) using P6-C4 chemistry, and reference genome assembly was performed as described ([@ref-4]).

Read mapping, variant calling and phylogenomic analysis
-------------------------------------------------------

The sequence reads were processed using *Nullarbor* (nullarbor.pl 0.6, <https://github.com/tseemann/nullarbor>), a recently developed bioinformatics pipeline for public health microbial genomics as described previously ([@ref-32]). *S. aureus* ST88 raw sequence reads with accession numbers ERS1354589-600 have been deposited in the European Nucleotide Archive (ENA), Project [PRJEB15428](PRJEB15428). Ortholog clustering was performed using Roary ([@ref-39]) and was visualized with Fripan (<http://drpowell.github.io/FriPan/>). Recombination within the core genome was inferred using ClonalFrameML v1.7 ([@ref-21]) with the whole genome alignment generated by Nullarbor. Using FastTree v2.1.8 ([@ref-40]), a ML tree was generated and used as a guide tree for ClonalFrameML. Positions in the reference genome that were not present in at least one genome (non-core) were omitted from the analysis using the "ignore_incomplete_sitestrue" option and providing ClonalFrameML with a list of all non-core positions. Maximum likelihood trees were constructed using a recombination free SNP alignment using FastTree. Bootstrap support was derived from comparisons between the original trees against 1,000 trees that were built upon pseudo-alignments (sampled from the original alignment with replacement).

Results and Discussion
======================

ST88 complete reference genome
------------------------------

A prerequisite for high-resolution comparative genomics by read-mapping is a high-quality, complete reference genome, closely related to the bacterial population under investigation ([@ref-32]). There were no fully assembled ST88 *S. aureus* genomes publicly available.

Hence, to address this issue, we selected the methicillin-susceptible, penicillin-resistant ST88 *S. aureus* isolate AUS0325. This clinical isolate was obtained in 2013 from a patient in Melbourne, Australia who had a persistent infection of a prosthetic joint, and was part of a separate, unpublished study. The AUS0325 genome comprised a 2,771,577 bp circular chromosome with 32.9% GC content. There were no plasmids; the beta-lactamase operon (*bla*) was carried by the Tn*552* transposon and integrated into the chromosome. The overall chromosome architecture of AUS0325 was like representative *S. aureus* genomes from other community-associated lineages (ST1, ST8 and ST93) but with five distinct regions of difference, discussed in more detail below ([Fig. 1A](#fig-1){ref-type="fig"}). We took advantage of the PacBio data to define the Sa_aus0325 methylome. Motif analysis and inspection of the AUS0325 annotation identified two active type I restriction modification *hsdMS* loci. Protein alignment of the two *hsdS* alleles with previously characterised *hsdS* proteins allowed the attribution of target recognition sequences to either allele ([@ref-34]) ([Table 2](#table-2){ref-type="table"}). The first *hsdS* recognized a motif not previously described, while the second *hsdS* contained an identical sequence to the target recognition domain-2 of CC30-2 and ST93-2, which recognises TCG ([Table 2](#table-2){ref-type="table"}).

![Comparative genomic analysis of *S. aureus* ST88.\
(A) DNA--DNA comparisons visualized using the Artemis comparison tool of three CA-MRSA representative chromosomes and *S. aureus* COL against the complete chromosome of ST88 isolate AUS0325. (B) Core genome phylogeny and accessory genome elements identified among ST88 isolates. The phylogeny was based on an alignment of 71,862 non-recombinogenic core genome SNPs (indels excluded) and inferred using FastTree. Nodes with greater than 70% bootstrap support (1,000 replicates) are labelled with red dots. Antibiotic resistance genes were identified using Abricate (<https://github.com/tseemann/abricate>) and genomic islands (GIs) enriched among ST88 isolates were identified by ortholog comparisons using Roary and visualized using FriPan. CDS present in specific GI are listed in [Table S1](#supp-3){ref-type="supplementary-material"}.](peerj-05-3047-g001){#fig-1}
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###### Sa_aus0325 methylome analysis.

![](peerj-05-3047-g005)

  HsdS (nucleotide position)   TRD1   *N*   TRD2
  ---------------------------- ------ ----- ------
  397,724 ≥ 399,280            ACC    5     RTGT
  1,849,852 ≤ 1,851,408        GAG    6     TCG

ST88 population structure
-------------------------

To understand the genomic diversity and evolutionary origin of the ST88 isolates, a core genome phylogeny was inferred by mapping reads from the 17 ST88 isolates ([Table 1](#table-1){ref-type="table"}; [Fig. 1B](#fig-1){ref-type="fig"}), two published ST88 MRSA genomes from Lebanon and USA and 15 other geographically and genetically distinct *S. aureus* clones to AUS0325 ([Table 3](#table-3){ref-type="table"}; [Fig. 1B](#fig-1){ref-type="fig"}). To assess the clonal ancestry, SNPs within inferred regions of recombination (71,862 clonal SNPs; 26,570 recombinogenic SNPs) ([Fig. S1](#supp-1){ref-type="supplementary-material"}) were removed and a maximum likelihood phylogenomic tree was established using the clonal core SNP alignment (71,862 SNPs). All 20 ST88 genomes formed a discrete, closely related lineage, defined by only 1,759 core genome SNPs, compared with 71,862 SNPs among all 35 *S. aureus* genomes ([Figs. 1B](#fig-1){ref-type="fig"} and [2A](#fig-2){ref-type="fig"}). The global tree was rooted using *Bacillus_subtilis*\_B4068 (GenBank ID: [JXHK00000000](JXHK00000000)) ([@ref-5]) as an out-group and this phylogeny indicated ST88 shares a most recent common ancestor (MRCA) with ST72 ([Fig. 1A](#fig-1){ref-type="fig"}).

10.7717/peerj.3047/table-3

###### Comparator reference genomes.

![](peerj-05-3047-g006)

  Sequence type   Region/country of origin   MSSA/MRSA   Reference strain                                           Assembly/accession number
  --------------- -------------------------- ----------- ---------------------------------------------------------- ------------------------------------
  ST8             USA/Canada                 CA-MRSA     *Staphylococcus aureus* subsp. *aureus* USA 300 FPR 3757   [NC_007793.1](NC_007793.1)
  ST 1            USA/Canada                 CA-MRSA     *Staphylococcus aureus* subsp. *aureus* MW2                [NC_003923.1](NC_003923.1)
  ST 80           Europe                     CA-MRSA     *Staphylococcus aureus* 11819-97                           [NC_017351.1](NC_017351.1)
  ST45            Europe/USA/Canada          CA-MRSA     *Staphylococcus aureus* subsp. *aureus* 300-169            [GCA_000534855.1](GCA_000534855.1)
  ST 30           Europe/Australia/Asia      CA-MRSA     *Staphylococcus aureus* subsp. *aureus*\_S2397             [GCA_000577595.1](GCA_000577595.1)
  ST 72           Asia                       CA-MRSA     *Staphylococcus aureus* MRSA_CVM43477                      [GCA_000830555.1](GCA_000830555.1)
  ST 59           Asia                       CA-MRSA     *Staphylococcus aureus* subsp. *aureus* M013               [NC_016928.1](NC_016928.1)
  ST93            Australia                  CA-MRSA     *Staphylococcus aureus* subsp. *aureus* JKD 6159           [NC_017338.1](NC_017338.1)
  ST 250          England                    HA-MRSA     *Staphylococcus aureus* subsp. *aureus* COL                [NC_002951.2](NC_002951.2)
  ST254           Japan                      MSSA        *Staphylococcus aureus* subsp. *aureus* Newman             [NC_009641.1](NC_009641.1)
  ST1             United Kingdom             MSSA        *Staphylococcus aureus* subsp. *aureus* MSSA476            [NC_002953.3](NC_002953.3)
  ST5             Ireland                    MSSA        *Staphylococcus aureus* subsp. *aureus* ED98               [NC_013450.1](NC_013450.1)
  ST5             Japan                      MRSA        *Staphylococcus aureus* subsp. *aureus* N315               [NC_002745.2](NC_002745.2)
  ST 239          Australia                  MRSA        *Staphylococcus aureus* subsp. *aureus* JKD 6008           [NC_017341.1](NC_017341.1)
  ST772           India                      MRSA        *Staphylococcus aureus* subsp. *aureus*\_ST772-MRSA        [GCA_000516935.1](GCA_000516935.1)
  ST 88           Lebanon                    MRSA        HST-105                                                    [GCA_000564895.1](GCA_000564895.1)
  ST 88           United States              MSSA        *Staphylococcus aureus* subsp. *aureus*\_21343             [GCA_000245595.2](GCA_000245595.2)

![High resolution ST88 phylogeny and accessory genome analysis.\
(A) Phylogeny inferred by read-mapping and variant identification among only ST88 genomes. Tree was produced using FastTree based on a pairwise alignment of 1,759 non-recombinogenic core genome SNPs among the 20 ST88 genomes. All major nodes in the tree (red circles) had greater than 70% bootstrap support (1,000 replicates). (B) Accessory gene content variation among the 20 ST88 genomes as assessed by ortholog comparisons using Roary. (C) Distinct genomic islands (GI) identified in Ghanaian isolates.](peerj-05-3047-g002){#fig-2}

Five distinct genomic regions were identified by ortholog comparisons, enriched among the ST88 genomes compared to the 15 other diverse *S. aureus* genomes. These regions included *ν*SAα (GI-3, [Fig. 1](#fig-1){ref-type="fig"}) that harboured 10 staphylococcal superantigen-like (*ssl*) genes, of which four were uniquely present in the ST88 isolates. Upregulation of SSLs has been reported in some CA-MRSA strains and may be involved in neutrophil and complement activation ([@ref-27]; [@ref-47]). GI-3 also harboured the first of the two functional type I restriction modification *hsdMS* loci (see above, [Table 2](#table-2){ref-type="table"}). GI-1 and GI-4 may be mobile integrative elements of unknown function with the presence of putative integrases and 4 and 12 CDS, respectively, all encoding hypothetical proteins. GI-1 also harbours elements of a putative restriction modification system ([Fig. 1](#fig-1){ref-type="fig"}; [Table S1](#supp-3){ref-type="supplementary-material"}). GI-2 contains 13 CDS. Most of unknown function although three CDS may encode membrane proteins ([Fig. 1](#fig-1){ref-type="fig"}; [Table S1](#supp-2){ref-type="supplementary-material"}). GI-5 had 14 CDS that included the second of the type I restriction modification *hsdMS* loci and seven CDS encoding putative proteases ([Table 2](#table-2){ref-type="table"}; [Table S1](#supp-3){ref-type="supplementary-material"}).

Evolution and molecular epidemiology of ST88 in Ghana
-----------------------------------------------------

To assess the evolutionary relationships among the ST88 genomes, a phylogenomic tree comprised exclusively of ST88 genomes was established using clonal, core SNPs (1,759 clonal SNPs; 207 recombinogenic SNPs) ([Fig. S2](#supp-2){ref-type="supplementary-material"}; [Fig. 2A](#fig-2){ref-type="fig"}). The tree was rooted using an ST93 genome (Sa_JKD6159) as an out-group. The phylogeny and the restricted genomic diversity (658 core SNPs) suggests that the spread of ST88 MRSA in Ghana is a recent phenomenon, with isolates from the United States, Australia and Lebanon ancestral to the spread of these isolates in Ghana. Five specific clusters of CDS were also found to be exclusively present with the African ST88 genomes ([Fig. 2C](#fig-2){ref-type="fig"}). These CDS were different to the five genomic regions identified in all ST88 relative to other *S. aureus* clones ([Fig. 1B](#fig-1){ref-type="fig"}) suggesting that they were horizontally acquired by an ST88 MRCA that has since spread in Ghana (although a significantly larger sampling effort would be required to confirm this hypothesis). These regions harbour CDS suggestive of plasmid, phage and other mobile DNA elements ([Table S2](#supp-4){ref-type="supplementary-material"}). We conducted a phylogeographic analysis to formally assess the relationship between the Ghanaian ST88 phylogeny and the specific geographic origin of the isolates, based on patient villages. However, there was no correlation between geography and phylogeny, suggesting again that the spread of ST88 in Ghana has been recent and rapid ([Fig. 3](#fig-3){ref-type="fig"}).

![Relationship between phylogeny of Ghanaian ST88 and their geographic origin.\
(A) Phylogeographic alignment of phylogeny against isolate origin geography performed with GenGIS software and (B) Monte-Carlo analysis following 1,000 permutations of tree tips and geography of originating villages. The arrangement derived from the data was not significantly different to that which is expected by chance alone (*p* \> 0.05), indicating a lack of geographical structure among the ST88 genomes.](peerj-05-3047-g003){#fig-3}

Phenotypic and genotypic antibiotic resistance
----------------------------------------------

All 17 Ghanaian ST88 isolates harboured a SCC*mec-*IV \[2B\] cassette, and displayed phenotypic resistance to *β*-lactams, tetracycline and chloramphenicol ([Table 1](#table-1){ref-type="table"}). Isolates were variably resistant to erythromycin, clindamycin, trimethoprim, amikacin and streptomycin ([Table 1](#table-1){ref-type="table"}). There was agreement between phenotypic and inferred genotypic resistance ([Fig. 1B](#fig-1){ref-type="fig"}). For the four genes (*blaZ, mecA, tetL* and *tetM*) detected in all 12 ST88 isolates from the Greater Accra Region, resistance correlated with phenotypic resistance to all *β*-lactams and tetracyclines. Six isolates showed phenotypic and genotypic resistance to chloramphenicol ([Table 1](#table-1){ref-type="table"}; [Fig. 1B](#fig-1){ref-type="fig"}). Five of these isolates were from the same health centre; however, the time of isolation and the geographic origins of the patients were different, suggesting that these isolates are widespread across the region and were not acquired from a common source.

Conclusion
==========

The analysis presented here suggests that *S. aureus* ST88-IV is an emerging CA-MRSA clone in Ghana. This has the potential to become a serious public health threat, with implications for the treatment of *S. aureus* infections in Ghana, where there is no developed surveillance infrastructure to monitor antibiotic resistance. The abuse and misuse of antibiotics by health care givers and patients in Ghana are extensive ([@ref-31]). The development of resistance is furthermore encouraged by the widespread availability of higher classes of antibiotics to lower level health centres from regional medical stores, in addition to the unrestricted sale of these medicines to over-the-counter medicine sellers by pharmaceutical wholesalers, even though existing laws are supposed to limit the scope of these facilities to handle such medicines. Also implicated and widely documented are the prescribing practices of clinicians; with over-reliance on presumptive treatment and haphazardly prescribing antibiotics without recourse to due laboratory investigation. CA-MRSA has undergone rapid evolution and expansion worldwide. Because of its epidemic potential and limited treatment options, vigilance and antibiotic stewardship programmes need to be put in place to prevent further spread.

Supplemental Information
========================
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###### Recombination analysis among the 20 ST88 and 15 non-ST88 genomes.

Light grey and black blocks denote recombination regions detected in ancestral nodes and the sampled genomes, respectively. In total there were 98,432 core SNPs, 26,570 of which were located within inferred regions of recombination. Red coloured isolates ST88, black; non-ST88 isolates.

###### 

Click here for additional data file.
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###### Recombination analysis among the 20 ST88 genomes.

Light grey and black blocks denote recombination regions detected in ancestral nodes and the sampled genomes, respectively. In total there were 1,966 core SNPs, 207 of which were located within inferred regions of recombination. Blue and red coloured isolates from the Greater Accra and Eastern Region of Ghana respectively. Pink coloured isolate from the United States, Green from Melbourne and Black from Lebanon.

###### 

Click here for additional data file.
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###### Genomic regions enriched in *S. aureus* MRSA ST88.

###### 

Click here for additional data file.
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###### Genome regions enriched in *S. aureus* MRSA ST88 from Ghana.

###### 

Click here for additional data file.
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